We take pride in our achievements and want to share our successes with you.
Updates on our latest news on IBsolvMIR will be added as soon as it’s available.
5 June 2018
Anders Kristensson appointed CEO of TikoMed
Viken – 18th June 2018 TikoMed, a privately-held biopharmaceutical company today announced the appointment of…Read More
22 April 2018
TIKOMED IS INTERVIEWED AT BIOSPRING ABOUT IBSOLVMIR FOR IMPROVED CELL-THERAPIES BY MIKE WARD
TikoMeds promising Phase 2 project for more efficient cell-therapies was presented at BioEurope Spring in…Read More